- CA$5.98bn
- CA$12.24bn
- CA$28.30bn
- 73
- 83
- 38
- 71
Annual income statement for Parkland, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 14,011 | 21,468 | 35,462 | 32,452 | 28,303 |
Cost of Revenue | |||||
Gross Profit | 2,307 | 2,972 | 4,021 | 3,968 | 3,716 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 13,653 | 20,772 | 34,332 | 31,654 | 27,817 |
Operating Profit | 358 | 696 | 1,130 | 798 | 486 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 154 | 162 | 416 | 508 | 127 |
Provision for Income Taxes | |||||
Net Income After Taxes | 112 | 126 | 346 | 471 | 127 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 82 | 97 | 310 | 471 | 127 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 82 | 97 | 310 | 471 | 127 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.548 | 1.18 | 2.54 | 3.32 | 2.08 |
Dividends per Share |